Browse diseases

…. The association with reduced survival among women with breast cancer may be a chance finding. However, this does not rule out an eff…

…ed (55.2%), and involved exercise professionals (76.7%). Breast cancer survivors comprised 44.3% of participants. Reported outcomes in…

…ry research that reports patient- or person-centred outcomes in cancer clinical trials. Studies focusing solely on preventative care o…

…CI treatment only induces durable responses in less than 20% of cancer patients.Methods To enhance the anti-tumor activity of pembroli…

…main, and an intracellular domain (EpICD). For several types of cancer, high EpCAM expression is associated with tumor progression, me…

…female (61%), had advanced cancer (stage IV- 71%), and had lung cancer (53%, 17% small cell lunger cancer, table 1). The cohort includ…

…ine education can significantly impact workforce development in cancer immunotherapy. As the field evolves, scalable and accessible mo…

… constrained MDSC and M2 TAM expansion and tumor growth in both fibrosarcoma and KP models. These effects were abolished in Rorc fl/fl Lyz2-…

…as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment. Nat Commun. 2022;11:1137.Ethics Approval All procedu…

…s might improve outcome for a broader spectrum of patients with cancer. Phosphoantigen-responsive Vγ9Vδ2-T cells are potent immune cel…

…e any cancer treatment. MN occurs along a spectrum, wherein the cancer cachexia syndrome is the most severe.2 Validated tools exist to…

…Introduction A cancer diagnosis not only profoundly impacts individuals but also the …